Baxter International (BAX) trades 3.8% lower premarket after it discloses along with partner...

|About: Baxter International Inc (BAX)|By:, SA News Editor

Baxter International (BAX) trades 3.8% lower premarket after it discloses along with partner Halozyme Therapeutics that the FDA needs more long-term data on their jointly-developed HyQ product.